Come up with a name for your new list and we'll add to it:
Proteon Therapeutics raised a round of funding on June 24, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a human recombinant protein that aims to permanently dilate segments of blood vessels, blocks vasospasm, and reduce the formatio…